Yuan-fang Liu

Suggest Changes

Writes About:

Learn More
OBJECTIVE To study whether all-trans retinoic acid (ATRA) combined with arsenic trioxide (As(2)O(3)) in acute promyelocytic leukemia (APL) treatment could further improve the clinical and molecular(More)